Skip to main content
Clinical Trials/NCT02339935
NCT02339935
Completed
Not Applicable

Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention

Vanderbilt University1 site in 1 country36 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
Vanderbilt University
Enrollment
36
Locations
1
Primary Endpoint
Aberrant Behavior Checklist
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study aims to implement and test a specific brief Applied Behavior Analysis model for assessing and responding to severe challenging behavior during acute medical and behavioral hospitalization for children with ASD. The investigators will evaluate the impact of this program by conducting a randomized trial across both medical and psychiatric hospital settings.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
November 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kevin Sanders

Principal Investigator

Vanderbilt University

Eligibility Criteria

Inclusion Criteria

  • documented diagnosis of an ASD based on clinical DSM-5 diagnostic criteria assessed by attending psychiatrist
  • the presence of a significant challenging behaviors (e.g., aggression, property destruction, self-injury, elopement)
  • admission to the VPH or medical floors
  • individual and caregiver agreement to participate and ability to provide informed consent (and assent).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Aberrant Behavior Checklist

Time Frame: Change from Baseline ABC at Hospital Discharge (an expected average of 42 days) and 3-Months Post-Discharge

The ABC is a well-validated measure designed to assess for the presence of clinically significant challenging behavior in the areas of irritability and agitation, lethargy and social withdrawal, stereotypic behavior, hyperactivity and noncompliance, and inappropriate speech.

Decrease in Length of Hospitalization

Time Frame: Participants will be followed from admission to discharge, an expected average of 42 days

Reduction in the days hospitalized past medical clearance).

Secondary Outcomes

  • Clinical Global Impression Scales of Severity(Baseline and Day of Patient's Discharge (an expected average of 42 days from admission))
  • Blinded Observational Ratings(Participants will be followed for duration of hospital stay, an expected average of 42 days)
  • Physician/Nurse/Family Perception of Care(Day of Patient's Discharge (an expected average of 42 days from admission))

Study Sites (1)

Loading locations...

Similar Trials